Immunic (IMUX) Balance Sheet: Assets & Liabilities

Immunic (IMUX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Immunic reported total assets of $24.05M and total liabilities of $30.73M. Shareholders' equity was negative at −$6.67M, meaning liabilities exceed assets. Total debt stood at $577.00K against $15.48M in cash and short-term investments, a net cash position of $14.91M.

Immunic Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Immunic, Inc. (IMUX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	15.48	35.67	46.67	106.75	86.86	127.45	29.37	13.32	56.90
Short-Term Investments	0.00	0.00	0.00	9.63	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	15.48	35.67	46.67	116.37	86.86	127.45	29.37	13.32	56.90
Accounts Receivable	4.12	0.68	2.48	2.66	2.15	1.64	0.41	0.00	0.00
Inventory	0.00	0.00	0.00	5.61	0.00	0.00	-0.41	-0.19	0.00
Other Current Assets	1.20	3.66	1.07	1.23	1.12	4.65	2.86	0.91	1.22
Total Current Assets	22.87	39.33	52.53	125.86	104.99	133.75	32.23	14.23	58.12
Non-Current Assets
Property, Plant & Equipment (Net)	1.18	1.54	1.77	1.85	1.10	1.10	0.71	0.71	2.16
Goodwill	0.00	0.00	0.00	0.00	32.97	32.97	32.97	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.04	0.04	0.04	0.04	0.04	0.11
Total Non-Current Assets	1.18	1.54	1.77	1.89	34.11	34.12	33.73	0.75	2.26
Total Assets	24.05	40.87	54.30	127.75	139.10	167.86	65.96	14.98	60.38
Current Liabilities
Accounts Payable	9.49	7.85	4.73	3.75	3.50	3.70	2.42	0.27	1.05
Short-Term Debt	0.47	0.74	0.70	0.57	0.41	0.30	0.00	0.00	0.00
Accrued Liabilities	16.48	12.91	17.20	7.10	6.40	4.32	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	1.01	0.00	0.00
Other Current Liabilities	1.37	1.42	0.27	0.24	0.18	0.08	3.64	2.24	9.23
Total Current Liabilities	30.62	22.18	24.73	13.08	11.40	8.40	7.07	2.51	10.28
Non-Current Liabilities
Long-Term Debt	0.11	0.26	0.64	0.99	0.58	0.68	0.52	0.00	0.00
Other Non-Current Liabilities	-0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.06
Total Non-Current Liabilities	0.11	0.26	0.64	0.99	0.58	0.68	0.52	0.04	0.06
Total Liabilities	30.73	22.44	25.37	14.07	11.99	9.08	7.59	2.55	10.34
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-608.57	-511.40	-410.89	-317.28	-196.87	-103.93	-59.91	-337.43	-295.95
Accumulated Other Comprehensive Income	2.65	4.21	3.76	3.04	-0.25	-4.11	-1.37	0.08	0.08
Additional Paid-in Capital	599.24	525.61	436.06	427.93	324.24	266.82	119.65	349.77	345.92
Shares Outstanding	12.04	9.02	4.52	3.93	26.34	-	-	-	-
Total Stockholders' Equity	-6.67	18.43	28.93	113.68	127.12	158.79	58.36	12.43	50.04
Total Liabilities & Equity	24.05	40.87	54.30	127.75	139.10	167.86	65.96	14.98	60.38

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Immunic Balance Sheet

How much debt does Immunic have?

Immunic had total debt of $577.00K as of Dec 31, 2025, against $15.48M in cash and short-term investments. Total debt was $1.00M a year earlier.

What are Immunic's total assets?

Immunic reported total assets of $24.05M as of Dec 31, 2025, down 41.1% from $40.87M a year earlier. Total liabilities were $30.73M.

What is Immunic's shareholders' equity?

Immunic's shareholders' equity was negative at −$6.67M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition